泰坦智華科技(00872.HK)接獲清盤呈請書 續停牌
泰坦智華科技(00872.HK)公布,於前日(3日)收到來自星展銀行根據清盤條例向香港高等法院所提交針對公司的清盤呈請書,該呈請基於公司根據貸款協議向星展銀行提供的擔保及彌償而提交,涉及未償還貸款的本金額及其應計利息。
清盤呈請將於今年12月6日於香港高等法院進行聆訊,泰坦智華表示,目前高等法院並未對公司發出清盤令,該呈請不代表其他持份者的利益,但可能損害公司價值,正就呈請的適當行動方案尋求法律建議,強調將採取一切必要行動保護其合法權利,以及公司及股東的整體利益。
應公司要求,股份已自2022年7月18日起暫停買賣,並將繼續停牌直至另行通告為止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.